Matteo Porotto Selected Research

Central Nervous System Diseases (CNS Diseases)

7/2010

Viral entry inhibitors targeted to the membrane site of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Porotto Research Topics

Disease

39	Infections 01/2023 - 05/2009
18	Paramyxoviridae Infections (Parainfluenza) 10/2023 - 02/2006
9	Measles 12/2023 - 02/2015
8	Virus Diseases (Viral Diseases) 11/2022 - 05/2009
8	COVID-19 01/2022 - 07/2020
4	Subacute Sclerosing Panencephalitis (SSPE) 02/2024 - 01/2019
3	Human Influenza (Influenza) 12/2021 - 02/2010
3	Bronchiolitis 01/2020 - 01/2012
3	Pneumonia (Pneumonitis) 01/2020 - 01/2012
3	Croup 01/2020 - 01/2012
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 11/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020 - 07/2010
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2019
2	Henipavirus Infections 01/2018 - 10/2010
1	Demyelinating Diseases (Demyelinating Disease) 02/2024
1	Disease Progression 02/2024
1	Morbillivirus Infections 12/2023
1	Viral Encephalitis 01/2023
1	Thrombosis (Thrombus) 01/2022
1	Persistent Infection 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2012
1	Central Nervous System Diseases (CNS Diseases) 07/2010
1	Vesicular Stomatitis 11/2009
1	Malaria 05/2009
1	Anemia 08/2008

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2009
23	Antiviral Agents (Antivirals)IBA 12/2023 - 07/2009
17	Peptides (Polypeptides)IBA 11/2022 - 07/2010
13	VaccinesIBA 12/2023 - 01/2012
13	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2009
9	LipopeptidesIBA 10/2022 - 01/2018
8	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2012
8	Neuraminidase (Sialidase)IBA 10/2023 - 02/2006
7	Carrier Proteins (Binding Protein)IBA 10/2023 - 10/2013
6	Hemagglutinins (Hemagglutinin)IBA 10/2023 - 12/2011
5	CholesterolIBA 12/2013 - 07/2010
3	InterferonsIBA 01/2023 - 01/2020
3	AntibodiesIBA 01/2021 - 07/2020
2	AerosolsIBA 10/2022 - 06/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2017
2	Amino Acids FDA Link 01/2021 - 01/2019
2	Immunoglobulin A (IgA)IBA 01/2021 - 07/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2020
2	Immunoglobulin M (IgM)IBA 01/2021 - 07/2020
2	sialic acid receptorIBA 10/2013 - 12/2012
2	Zanamivir (Relenza)FDA Link 04/2007 - 02/2006
1	Viral ProteinsIBA 02/2024
1	NucleosidesIBA 02/2024
1	remdesivirIBA 02/2024
1	nitazoxanide (NTZ)FDA Link 12/2023
1	Interferon Type IIBA 01/2023
1	AnticoagulantsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	LipidsIBA 08/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	HN ProteinIBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Protein CIBA 10/2018
1	peptide AIBA 12/2011
1	oplunofuspIBA 07/2010
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2010
1	GliotoxinIBA 11/2009
1	Viral HemagglutininsIBA 07/2009
1	Chloroquine (Aralen)FDA LinkGeneric 05/2009
1	TG101209IBA 08/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2010
2	Intranasal Administration 01/2021 - 11/2020
1	Aftercare (After-Treatment) 02/2024
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2020